Foamix Pharmaceuticals logo

Foamix Pharmaceuticals

31 employees · est. 2003 · Rehovot, Israel

VS
ImageneBio logo

ImageneBio

49 employees · est. 2019 · San Diego, United States

Foamix Pharmaceuticals is the older company (2003 vs 2019).

Side-by-Side Comparison

Foamix Pharmaceuticals ImageneBio
Founded
2003 older 2019
Headquarters
Rehovot, Israel San Diego, United States
Employees
31 49
Industry
Health Care, Pharmaceutical Biopharma, Biotechnology, Health Care
Funding Stage
Post Ipo Debt Series C
Total Funding
Not tracked yet $121.00M
Funding Rounds
Not tracked yet 2
Services
Not tracked yet Development of therapeutics for immunological, autoimmune, and inflammatory diseases, Clinical-stage drug development, Anti-OX40 monoclonal antibody development
Target Customers
Not tracked yet Patients with immunological diseases, Patients with autoimmune diseases, Patients with inflammatory diseases, Healthcare professionals, Investors in biotechnological solutions
Taxonomy
Not tracked yet Pharmaceuticals, Drug Development, Global Innovation, Immunology, Inflammation, Clinical-stage Assets, Cutting-edge Technology, Medical Research, Therapeutic Innovation
Website
foamix.com imagenebio.com
Foamix Pharmaceuticals logo

About Foamix Pharmaceuticals

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) is a clinical stage specialty pharmaceutical company founded in 2003, headquartered in Israel. The company is dedicated to developing and commercializing proprietary topical foams to address unmet needs in dermatology. Their innovative product candidates in...

ImageneBio logo

About ImageneBio

ImageneBio is a clinical-stage biotechnology company founded in 2019. Headquartered in the United States, the company focuses on developing innovative therapeutics for patients suffering from immunological, autoimmune, and inflammatory diseases. These programs aim to offer differentiated clinical pr...

We will tell you when either one moves

BounceWatch watches Foamix Pharmaceuticals and ImageneBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Foamix Pharmaceuticals and ImageneBio — by email.

Frequently Asked Questions

Foamix Pharmaceuticals. ImageneBio. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Foamix Pharmaceuticals has raised undisclosed funding while ImageneBio has raised $121.00M.
Foamix Pharmaceuticals and ImageneBio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Foamix Pharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ImageneBio on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes